Home › Therapeutic areas › Oncology › Hodgkin Lymphoma

Hodgkin Lymphoma (2 companies)

Companies with an active program in Hodgkin Lymphoma.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CMPX Compass Therapeutics Oncology 1 Phase 2 $109M 15
MRKR Marker Therapeutics Oncology 1 Phase 1 $14.0M 5